Analyst Consensus ?
1 unmapped firm rating excluded from the percentages.
FedEx Corporation · FDX · FY2026 Q4 · Calendar Q2 2026
FedEx closed fiscal year 2026 with a decisive top- and bottom-line beat — EPS of $6.31 against $5.91 consensus and revenue of $25.0 billion versus $22.79 billion estimated — capping a transformative year. The company completed the FedEx Freight spin-off on June 1, launched FedEx Life Sciences with a temperature-controlled Ireland-to-U.S. corridor, and announced the InPost acquisition. Management introduced calendar-year guidance of CY2026 adjusted EPS of $16.90 to $18.10 (roughly 20% growth) with revenue growth of approximately 11%. Network 2.0 now routes about 45% of eligible volume through optimized stations, targeting 65% before peak season. Premium B2B verticals — healthcare, automotive, aerospace, and AI/data-center logistics — are the primary growth engine. Adjusted free cash flow reached $4.7 billion; the dividend was raised 5% and up to $1 billion in share repurchases were…
FedEx Corporation is a prominent global entity that delivers an extensive array of services encompassing transportation, e-commerce solutions, and diverse business support, catering to clients both within the United States and across international borders. Its operational structure is divided into several key segments: The FedEx Express division specializes in expedited shipping, offering rapid package and freight delivery, crucial time-sensitive logistics, and comprehensive cross-border, technological, and e-commerce transportation services. FedEx Ground focuses on reliable, scheduled delivery services for both commercial clients and individual households.…
1 unmapped firm rating excluded from the percentages.
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Jul 29, 2026. Not an FN2 forecast.
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Truist Securities | Buy | Buy | Maintain | Jun 25, 2026 |
| UBS | Buy | Buy | Maintain | Jun 24, 2026 |
| Stifel | Buy | Buy | Maintain | Jun 24, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 24, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jun 24, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jun 17, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jun 12, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Jun 3, 2026 |
| BMO Capital | Market Perform | Market Perform | Maintain | Jun 2, 2026 |
| JP Morgan | Overweight | Neutral | Upgrade | May 27, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Apr 14, 2026 |
| Argus Research | Buy | Buy | Maintain | Apr 6, 2026 |
| Susquehanna | Positive | Positive | Maintain | Mar 20, 2026 |
| Evercore ISI Group | In Line | In Line | Maintain | Mar 20, 2026 |
| TD Cowen | Buy | Buy | Maintain | Feb 13, 2026 |
| Rothschild & Co | Neutral | Buy | Downgrade | Jan 21, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jan 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Dec 19, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Jun 25, 2025 |
| Loop Capital | Sell | Hold | Downgrade | Mar 21, 2025 |
| HSBC | Hold | Buy | Downgrade | Sep 20, 2024 |
| Baird | Outperform | Outperform | Maintain | Sep 20, 2024 |
| Oppenheimer | Perform | Perform | Maintain | Jun 26, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Jun 26, 2024 |
| Exane BNP Paribas | Underperform | Neutral | Downgrade | Mar 27, 2024 |
| Melius Research | Buy | Hold | Upgrade | Jan 8, 2024 |
| Deutsche Bank | Buy | Buy | Maintain | Sep 22, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jun 22, 2023 |
| Keybanc | Overweight | Downgrade | Sep 16, 2022 | |
| Cowen & Co. | Outperform | Outperform | Maintain | Sep 16, 2022 |
| Berenberg | Hold | Buy | Downgrade | Jul 1, 2022 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | May 3, 2021 |
| Bank of America | Neutral | Neutral | Maintain | Mar 20, 2019 |
| Argus | Buy | Buy | Maintain | May 5, 2018 |
| Stifel Nicolaus | Buy | Hold | Upgrade | Mar 21, 2018 |
| Standpoint Research | Hold | Buy | Downgrade | Mar 17, 2016 |
| Nomura | Neutral | Neutral | Maintain | Mar 17, 2016 |
| Avondale Partners | Market Outperform | Market Outperform | Maintain | Mar 17, 2016 |
| Buckingham Research | Neutral | Neutral | Maintain | Sep 17, 2015 |
| Keefe, Bruyette & Woods | Market Perform | Market Perform | Maintain | Sep 2, 2015 |
| Keefe Bruyette & Woods | Market Perform | Market Perform | Maintain | Sep 2, 2015 |
| RBC Capital | Sector Perform | Sector Perform | Maintain | Jun 11, 2015 |
| Macquarie | Outperform | Outperform | Maintain | Sep 18, 2014 |
| PiperJaffray | Buy | Buy | Maintain | Nov 27, 2013 |
| Piper Sandler | Buy | Buy | Maintain | Nov 27, 2013 |
| BB&T Capital | Hold | Buy | Downgrade | Feb 27, 2013 |
| Standpoint | Hold | Buy | Downgrade | Jan 23, 2013 |
| Dahlman Rose | Buy | Buy | Maintain | Sep 18, 2012 |
Upside is calculated against the persisted current price $310.15. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Evercore ISI | Analyst unavailable | $165 | $329.44 | -46.8% | Jun 26, 2026 |
| Truist Financial | Analyst unavailable | $365 | $316.83 | +17.7% | Jun 25, 2026 |
| Bernstein | David Vernon | $397 | $315.12 | +28.0% | Jun 24, 2026 |
| UBS | Thomas Wadewitz | $350 | $317.24 | +12.8% | Jun 24, 2026 |
| Stifel Nicolaus | Bruce Chan | $326 | $317.24 | +5.1% | Jun 24, 2026 |
| Jefferies | Stephanie Moore | $200 | $328.78 | -35.5% | Jun 23, 2026 |
| Stifel Nicolaus | Bruce Chan | $442 | $330 | +42.5% | Jun 22, 2026 |
| Bernstein | Analyst unavailable | $424 | $326.2 | +36.7% | Jun 18, 2026 |
| Wells Fargo | Analyst unavailable | $425 | $335.74 | +37.0% | Jun 17, 2026 |
| Barclays | Analyst unavailable | $425 | $338 | +37.0% | Jun 12, 2026 |
| Morgan Stanley | Analyst unavailable | $160 | $329 | -48.4% | Jun 3, 2026 |
| Raymond James | Patrick Tyler | $180 | $329 | -42.0% | Jun 3, 2026 |
| Truist Financial | Lucas Servera | $155 | $338.49 | -50.0% | Jun 2, 2026 |
| BMO Capital | Fadi Chamoun | $340 | $334.68 | +9.6% | Jun 1, 2026 |
| UBS | Thomas Wadewitz | $445 | $388.91 | +43.5% | May 22, 2026 |
| Bernstein | David Vernon | $457 | $355.35 | +47.3% | Mar 6, 2026 |
| HSBC | Analyst unavailable | $335 | $384.59 | +8.0% | Feb 25, 2026 |
| Evercore ISI | Jonathan Chappell | $380 | $386.12 | +22.5% | Feb 24, 2026 |
| Stifel Nicolaus | Bruce Chan | $412 | $375.53 | +32.8% | Feb 13, 2026 |
| Evercore ISI | Analyst unavailable | $364 | $371.19 | +17.4% | Feb 13, 2026 |
| Deutsche Bank | Analyst unavailable | $479 | $366.74 | +54.4% | Feb 13, 2026 |
| Wells Fargo | Christian Wetherbee | $430 | $369.46 | +38.6% | Feb 13, 2026 |
| Goldman Sachs | Jordan Alliger | $364 | $369.46 | +17.4% | Feb 12, 2026 |
| Barclays | Analyst unavailable | $450 | $364.6 | +45.1% | Feb 10, 2026 |
| UBS | Thomas Wadewitz | $412 | $353.43 | +32.8% | Feb 4, 2026 |
| Bernstein | Analyst unavailable | $427 | $335.3 | +37.7% | Feb 3, 2026 |
| Wells Fargo | Analyst unavailable | $380 | $335.3 | +22.5% | Feb 3, 2026 |
| Redburn Partners | Analyst unavailable | $317 | $301.03 | +2.2% | Jan 21, 2026 |
| Redburn Partners | Analyst unavailable | $271 | $301.03 | -12.6% | Jan 21, 2026 |
| Wolfe Research | Analyst unavailable | $355 | $301.03 | +14.5% | Jan 21, 2026 |
| BNP Paribas | Hugo Watkins | $280 | $311.92 | -9.7% | Jan 13, 2026 |
| Bernstein | Analyst unavailable | $306 | $309.01 | -1.3% | Jan 9, 2026 |
| Stifel Nicolaus | Analyst unavailable | $328 | $284.02 | +5.8% | Dec 19, 2025 |
| BMO Capital | Fadi Chamoun | $290 | $287.12 | -6.5% | Dec 19, 2025 |
| Morgan Stanley | Ravi Shanker | $210 | $287.12 | -32.3% | Dec 19, 2025 |
| Truist Financial | Lucas Servera | $330 | $286.2 | +6.4% | Dec 19, 2025 |
| Jefferies | Stephanie Moore | $326 | $287.12 | +5.1% | Dec 19, 2025 |
| Wells Fargo | Analyst unavailable | $295 | $287.12 | -4.9% | Dec 19, 2025 |
| Deutsche Bank | Analyst unavailable | $322 | $284.81 | +3.8% | Dec 17, 2025 |
| Stifel Nicolaus | Analyst unavailable | $305 | $281.23 | -1.7% | Dec 16, 2025 |
| Wells Fargo | Analyst unavailable | $290 | $274.29 | -6.5% | Dec 8, 2025 |
| Stifel Nicolaus | Analyst unavailable | $297 | $267.76 | -4.2% | Nov 20, 2025 |
| Truist Financial | Lucas Servera | $285 | $230.66 | -8.1% | Oct 14, 2025 |
| Stephens | Analyst unavailable | $260 | $229.65 | -16.2% | Oct 14, 2025 |
| BMO Capital | Fadi Chamoun | $255 | $226.5 | -17.8% | Sep 19, 2025 |
| Raymond James | Patrick Tyler Brown | $255 | $225.27 | -17.8% | Sep 18, 2025 |
| Evercore ISI | Analyst unavailable | $243 | $227.7 | -21.7% | Sep 16, 2025 |
| Bernstein | David Vernon | $247 | $226.18 | -20.4% | Sep 16, 2025 |
| Stifel Nicolaus | Bruce Chan | $315 | $222 | +1.6% | Jun 25, 2025 |
| Stifel Nicolaus | Analyst unavailable | $354 | $230.33 | +14.1% | Mar 21, 2025 |
| Loop Capital Markets | Analyst unavailable | $221 | $230.33 | -28.7% | Mar 21, 2025 |
| Deutsche Bank | Analyst unavailable | $337 | $253.92 | +8.7% | Mar 7, 2025 |
| Bernstein | David Vernon | $320 | $274.97 | +3.2% | Dec 20, 2024 |
| Citigroup | Ariel Rosa | $301 | $261.4 | -3.0% | Oct 8, 2024 |
| Loop Capital Markets | Rick Paterson | $288 | $254.64 | -7.1% | Sep 23, 2024 |
| Stephens | Daniel Imbro | $350 | $260.5 | +12.8% | Sep 20, 2024 |
| Bank of America Securities | Ken Hoexter | $308 | $253.93 | -0.7% | Sep 20, 2024 |
| BMO Capital | Fadi Chamoun | $300 | $255.97 | -3.3% | Sep 20, 2024 |
| HSBC | Parash Jain | $300 | $300.39 | -3.3% | Sep 20, 2024 |
| Raymond James | Patrick Tyler Brown | $310 | $253.94 | -0.0% | Sep 20, 2024 |
| Jefferies | Stephanie Moore | $275 | $253.78 | -11.3% | Sep 20, 2024 |
| Susquehanna | Bascome Majors | $330 | $253.78 | +6.4% | Sep 20, 2024 |
| Stifel Nicolaus | Bruce Chan | $321 | $300.39 | +3.5% | Sep 20, 2024 |
| Robert W. Baird | Garrett Holland | $320 | $300.39 | +3.2% | Sep 20, 2024 |
| Goldman Sachs | Jordan Alliger | $332 | $298.86 | +7.0% | Sep 18, 2024 |
| Bank of America Securities | Ken Hoexter | $345 | $297.34 | +11.2% | Sep 18, 2024 |
| Loop Capital Markets | Rick Paterson | $317 | $311.49 | +2.2% | Jul 18, 2024 |
| BMO Capital | Fadi Chamoun | $325 | $291.65 | +4.8% | Jun 27, 2024 |
| Argus Research | John Eade | $335 | $296.19 | +8.0% | Jun 27, 2024 |
| Stephens | Daniel Imbro | $325 | $296.19 | +4.8% | Jun 26, 2024 |
| Goldman Sachs | Jordan Alliger | $333 | $256.38 | +7.4% | Jun 26, 2024 |
| Robert W. Baird | Garrett Holland | $340 | $256.38 | +9.6% | Jun 26, 2024 |
| Evercore ISI | Jonathan Chappell | $318 | $253.66 | +2.5% | Jun 24, 2024 |
| UBS | Thomas Wadewitz | $333 | $254.71 | +7.4% | May 21, 2024 |
| Barclays | Brandon Oglenski | $350 | $254.71 | +12.8% | May 20, 2024 |
| Stifel Nicolaus | Bruce Chan | $303 | $275.29 | -2.3% | Apr 3, 2024 |
| Goldman Sachs | Jordan Alliger | $324 | $283.63 | +4.5% | Mar 22, 2024 |
| Stifel Nicolaus | Bruce Chan | $306 | $284.32 | -1.3% | Mar 22, 2024 |
| UBS | Thomas Wadewitz | $340 | $284.32 | +9.6% | Mar 22, 2024 |
| BMO Capital | Fadi Chamoun | $310 | $284.32 | -0.0% | Mar 22, 2024 |
| Jefferies | Stephanie Moore | $300 | $284.32 | -3.3% | Mar 22, 2024 |
| Stifel Nicolaus | Bruce Chan | $290 | $259.99 | -6.5% | Mar 20, 2024 |
| Melius Research | Conor Cunningham | $310 | $248.59 | -0.0% | Jan 8, 2024 |
| Goldman Sachs | Jordan Alliger | $293 | $246.77 | -5.5% | Dec 20, 2023 |
| UBS | Thomas Wadewitz | $323 | $281.92 | +4.1% | Dec 19, 2023 |
| HSBC | Parash Jain | $330 | $264.95 | +6.4% | Oct 2, 2023 |
| Evercore ISI | Jonathan Chappell | $276 | $253.08 | -11.0% | Sep 20, 2023 |
| Morgan Stanley | Ravi Shanker | $200 | $255.44 | -35.5% | Sep 11, 2023 |
| Loop Capital Markets | Fadi Chamoun | $260 | $225.84 | -16.2% | Jun 21, 2023 |
| Raymond James | Patrick Tyler Brown | $270 | $230.56 | -12.9% | Jun 21, 2023 |
| Credit Suisse | Ariel Rosa | $273 | $235.12 | -12.0% | Jun 16, 2023 |
| Morgan Stanley | Ravi Shanker | $180 | $221.72 | -42.0% | Jun 2, 2023 |
| Citigroup | Christian Wetherbee | $285 | $232.26 | -8.1% | Apr 6, 2023 |
| Raymond James | Patrick Tyler Brown | $285 | $229.93 | -8.1% | Apr 6, 2023 |
| Bernstein | David Vernon | $246 | $220.07 | -20.7% | Mar 17, 2023 |
| Evercore ISI | Jonathan Chappell | $234 | $195.3 | -24.6% | Mar 16, 2023 |
| Citigroup | Christian Wetherbee | $240 | $213.26 | -22.6% | Feb 2, 2023 |
| Morgan Stanley | Analyst unavailable | $145 | $190.92 | -53.2% | Jan 9, 2023 |
| Jefferies | Analyst unavailable | $175 | $177.2 | -43.6% | Dec 22, 2022 |
| DNB Markets | Ken Hoexte | $185 | $172.32 | -40.4% | Dec 21, 2022 |
| Evercore ISI | Analyst unavailable | $196 | $169.88 | -36.8% | Dec 21, 2022 |
| Susquehanna | Analyst unavailable | $170 | $171.57 | -45.2% | Dec 21, 2022 |
| Credit Suisse | Analyst unavailable | $211 | $172.2 | -32.0% | Dec 21, 2022 |
| UBS | Analyst unavailable | $225 | $164.35 | -27.5% | Dec 21, 2022 |
| J.P. Morgan | Analyst unavailable | $179 | $164.35 | -42.3% | Dec 21, 2022 |
| Evercore ISI | Analyst unavailable | $202 | $168.78 | -34.9% | Dec 19, 2022 |
| Wells Fargo | Analyst unavailable | $185 | $177.37 | -40.4% | Dec 13, 2022 |
| Deutsche Bank | Analyst unavailable | $217 | $173.21 | -30.0% | Nov 29, 2022 |
| Credit Suisse | Ariel Rosa | $178 | $154.54 | -42.6% | Sep 23, 2022 |
| Deutsche Bank | Amit Mehrotra | $190 | $154.54 | -38.7% | Sep 23, 2022 |
| Goldman Sachs | Jordan Alliger | $215 | $149.33 | -30.7% | Sep 23, 2022 |
| Stifel Nicolaus | J. Bruce Chan | $181 | $149.33 | -41.6% | Sep 23, 2022 |
| Stifel Nicolaus | Bruce Chan | $186 | $159.6 | -40.0% | Sep 16, 2022 |
| Credit Suisse | Ariel Rosa | $246 | $161.02 | -20.7% | Sep 16, 2022 |
| Stifel Nicolaus | J. Bruce Chan | $195 | $161.02 | -37.1% | Sep 16, 2022 |
| Goldman Sachs | Jordan Alliger | $250 | $161.02 | -19.4% | Sep 16, 2022 |
| Morgan Stanley | Ravi Shanker | $255 | $222.98 | -17.8% | Jul 13, 2022 |
| Credit Suisse | Ariel Rosa | $314 | $230.49 | +1.2% | Jul 11, 2022 |
| Berenberg Bank | William Howard | $275 | $226.71 | -11.3% | Jul 1, 2022 |
| Wells Fargo | Allison Poliniak-Cusic | $282 | $234.2 | -9.1% | Jun 29, 2022 |
| Evercore ISI | Duane Pfennigwerth | $307 | $234.6 | -1.0% | Jun 29, 2022 |
| Stephens | Jack Atkins | $295 | $240.47 | -4.9% | Jun 28, 2022 |
| Loop Capital Markets | Rick Paterson | $339 | $240.47 | +9.3% | Jun 28, 2022 |
| UBS | Thomas Wadewitz | $312 | $240.47 | +0.6% | Jun 28, 2022 |
| Morgan Stanley | Ravi Shanker | $245 | $221.72 | -21.0% | Jun 2, 2022 |
| Truist Financial | Ki Bin Kim | $166 | $210.01 | -46.5% | May 11, 2022 |
| Morgan Stanley | Ravi Shanker | $250 | $217.99 | -19.4% | Apr 4, 2022 |
| Deutsche Bank | Amit Mehrotra | $298 | $230.05 | -3.9% | Mar 28, 2022 |
| Barclays | Brandon Oglenski | $320 | $218.91 | +3.2% | Mar 18, 2022 |
| J.P. Morgan | Brian Ossenbeck | $282 | $218.91 | -9.1% | Mar 18, 2022 |
| UBS | Thomas Wadewitz | $310 | $218.91 | -0.0% | Mar 18, 2022 |
| Stephens | Jack Atkins | $285 | $218.91 | -8.1% | Mar 18, 2022 |
| Wolfe Research | Scott Group | $268 | $218.91 | -13.6% | Mar 18, 2022 |
| Wells Fargo | Allison Poliniak | $277 | $218.91 | -10.7% | Mar 18, 2022 |
| Credit Suisse | Ariel Rosa | $294 | $218.91 | -5.2% | Mar 18, 2022 |
| KeyBanc | Todd Fowler | $300 | $211.13 | -3.3% | Mar 14, 2022 |
| Bernstein | Alex Irving | $333 | $213.18 | +7.4% | Mar 11, 2022 |
| Goldman Sachs | Jordan Alliger | $343 | $244.89 | +10.6% | Jan 24, 2022 |
| Stifel Nicolaus | J. Bruce Chan | $288 | $249.47 | -7.1% | Dec 17, 2021 |
| Loop Capital Markets | Rick Paterson | $324 | $227.45 | +4.5% | Sep 23, 2021 |
| Susquehanna | Bascome Majors | $280 | $227.6 | -9.7% | Sep 22, 2021 |
Track every rating change on FDX the moment it posts. Free to start.
Start freeFollow FDX with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeThree structural changes define the quarter. First, the FedEx Freight spin-off was completed on June 1, 2026, positioning both entities as focused industry leaders; the prior quarter had set the schedule and arranged $3.7 billion in debt financing. Second, Network 2.0 advanced from roughly 35% to about 45% of eligible volume flowing through optimized stations, with the 65% pre-peak target reaffirmed. Third, management introduced calendar-year guidance (CY2026 adjusted EPS $16.90 to $18.10, revenue growth about 11%) alongside final fiscal-year results, replacing the prior FY2026 adjusted EPS range of $19.30 to $20.10. New initiatives include FedEx Life Sciences, the Tricolor air-freight service, and a temperature-controlled Ireland-to-U.S. health-care corridor targeting the $80 billion market. CapEx outlook shifted from decreasing to increasing.
Prior quarter (Q3 FY2026): raised FY2026 adjusted EPS guidance to $19.30 to $20.10; CapEx at or below $4.1 billion (down $400 million from prior outlook); capex outlook decreasing. Current quarter (Q4 FY2026): introduced CY2026 adjusted EPS guidance of $16.90 to $18.10 (approximately 20% growth) and revenue growth of about 11% including fuel-surcharge benefit. CapEx outlook shifted to increasing. Guidance sentiment remains raised and management tone is confident. The guidance basis changed from fiscal year (ending May 2026) to calendar year 2026, so the two ranges are not directly comparable.
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated . For educational purposes only; not investment advice.